Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Amy Early"'
Autor:
Sabah Alaklabi, Arya Mariam Roy, Kristopher Attwood, Anthony George, Tracey O’Connor, Amy Early, Ellis G. Levine, Shipra Gandhi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIt is critically important to study the real-world data of FDA-approved medications to understand the response rates and toxicities observed in the real-world population not represented in the clinical trials.MethodsWe reviewed charts of pa
Externí odkaz:
https://doaj.org/article/e7f56b784faa4b85b0df5d1bf3c39650
Autor:
Sarabjot Pabla, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jacob Hagen, Vincent Giamo, Jonathan Andreas, Felicia L. Lenzo, Wang Yirong, Grace K. Dy, Edwin Yau, Amy Early, Hongbin Chen, Wiam Bshara, Katherine G. Madden, Keisuke Shirai, Konstantin Dragnev, Laura J. Tafe, Daniele Marin, Jason Zhu, Jeff Clarke, Matthew Labriola, Shannon McCall, Tian Zhang, Matthew Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Arun Singavi, Ben George, Andrew Craig MacKinnon, Jonathan Thompson, Rajbir Singh, Robin Jacob, Lynn Dressler, Mark Steciuk, Oliver Binns, Deepa Kasuganti, Neel Shah, Marc Ernstoff, Kunle Odunsi, Razelle Kurzrock, Mark Gardner, Lorenzo Galluzzi, Carl Morrison
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local immunosuppression independent of major ICI targets (e.g., PD-1). Clinical experience with response prediction based on PD-L1 expression suggests that other
Externí odkaz:
https://doaj.org/article/4f4efc20d258452fa94c335442c051f9
Autor:
Grace K. Dy, Mary K. Nesline, Antonios Papanicolau-Sengos, Paul DePietro, Charles M. LeVea, Amy Early, Hongbin Chen, Anne Grand’Maison, Patrick Boland, Marc S. Ernstoff, Stephen Edge, Stacey Akers, Mateusz Opyrchal, Gurkamal Chatta, Kunle Odunsi, Sarabjot Pabla, Jeffrey M. Conroy, Sean T. Glenn, Hanchun T. DeFedericis, Blake Burgher, Jonathan Andreas, Vincent Giamo, Maochun Qin, Yirong Wang, Kazunori Kanehira, Felicia L. Lenzo, Peter Frederick, Shashikant Lele, Lorenzo Galluzzi, Boris Kuvshinoff, Carl Morrison
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Regulatory approval of next generation sequencing (NGS) by the FDA is advancing the use of genomic-based precision medicine for the therapeutic management of cancer as standard care. Recent FDA guidance for the classification of g
Externí odkaz:
https://doaj.org/article/5167cae0cf364fa38ba58c2973088fd1
Autor:
Pawel Kalinski, Peter Forsyth, Mateusz Opyrchal, Hung Khong, Amy Early, Brian Czerniecki, Shipra Gandhi, Kamran Ahmed, Kristopher Attwood, Ellis Levine, Tracey O’Connor, Robert Fenstermaker, Dheerendra Prasad, Kazuaki Takabe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d199021577a24a39a6ed5e551fe43dc4
Autor:
Mark G, Faber, Chong, Wang, Sruthi, Kommi Reddy, Alison, Meagher, Amy, Early, Hongbin, Chen, Grace K, Dy
Publikováno v:
Lung Cancer. 165:49-53
Maintenance therapy with pemetrexed has shown survival benefit in patients with advanced stage non-small cell lung cancer (NSCLC). The recommended dose schedule is 500 mg/m 2 in 21-day cycles. Prolonged treatment with maintenance pemetrexed can resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93f16ed86bef29b1bc5017d11536901
https://doi.org/10.1016/j.lungcan.2022.01.010
https://doi.org/10.1016/j.lungcan.2022.01.010
Autor:
Maithreyi Sarma, Stuthi Perimbeti, Samar Nasir, Kristopher Attwood, Ankita Kapoor, Tracey O’Connor, Amy Early, Ellis G. Levine, Kazuaki Takabe, Pawel Kalinski, Christine Ambrosone, Thaer Khoury, Song Yao, Shipra Gandhi
Publikováno v:
Breast Cancer Res Treat
PURPOSE: To examine the association between race and clinical outcomes (pathological complete response [pCR]; recurrence free survival [RFS], and overall survival [OS]) in patients diagnosed with triple-negative (TNBC) or HER2-positive breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e08fc592d2e90b5b753c21eba0c36a
https://doi.org/10.1007/s10549-021-06506-y
https://doi.org/10.1007/s10549-021-06506-y
Autor:
Yolanda, Suarez-Balcazar, Amy, Early, Daniela E, Miranda, Hannah, Marquez, Ashley, Maldonado, Manuel, Garcia-Ramirez
Publikováno v:
American Journal of Community Psychology. 70:89-101
Asset mapping is a participatory methodology that engages community members in identifying services and settings that promote health and well-being. This study aimed to identify community assets from the perspective of Latinx immigrant families with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd2261d33babe08810d5592794e629cc
https://doi.org/10.1002/ajcp.12578
https://doi.org/10.1002/ajcp.12578
Autor:
Kristin Harkins, David X. Marquez, Amy Early, Ashley M Maldonado, Guilherme M. Balbim, Lesley Steinman
Publikováno v:
Hisp Health Care Int
Introduction: We aimed to evaluate the resonance of public health messages promoting early detection of dementia in adult Latinos with a living older adult loved one. Method: We conducted a mixed-methods study with focus groups and surveys to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd8866bb5232f9d83de4566772ca1b24
https://doi.org/10.1177/1540415320908535
https://doi.org/10.1177/1540415320908535
Publikováno v:
Work. 63:309-318
As the population of individuals aged sixty-five and older continues to grow, the number of older individuals participating in the workforce rises alongside, with projections estimating as many as 72 million older workers by 2030. Due to this rapid i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43c4b612d2d52356b098b2cb82bb7f2
https://doi.org/10.3233/wor-192924
https://doi.org/10.3233/wor-192924
Autor:
Edwin H. Yau, Bojidar Kandar, Lei Deng, Te-An Chen, Wiam Bshara, Sean Glenn, Sarabjot Pabla, Antonios Papanicolau-Sengos, Mary Nesline, Hongbin Chen, Amy Early, Carl Morrison, Grace Dy
Publikováno v:
Cancer Research. 82:1320-1320
Background: The use of immune PD-1/-L1 checkpoint inhibitors (ICI) has dramatically altered the treatment of advanced non-small cell lung cancer (NSCLC). However, a large proportion of patients with NSCLC do not derive clinical benefit from ICI treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc1a7c9a4eab022eeb36d10a1733ec1d
https://doi.org/10.1158/1538-7445.am2022-1320
https://doi.org/10.1158/1538-7445.am2022-1320